Sintilimab-associated hemophagocytic lymphohistiocytosis: a case report
Hemophagocytic lymphohistiocytosis (HLH) is a rare hematologic syndrome characterized by massive, uncontrolled cytokine release, which can lead to multiple organ failure and is associated with a high mortality rate. Recent studies have found that checkpoint inhibitors (ICIs) can induce HLH. This cas...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-05-01
|
| Edice: | Frontiers in Immunology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1821839/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|